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Abstract
Background: Chlamydia trachomatis is a common sexually transmitted infection that can have serious
consequences. It is universally agreed that screening for chlamydia infection should be offered to sexually
active young women. We undertook a literature review to document the views, attitudes and opinions of
women about being screened, tested and diagnosed with Chlamydia trachomatis.
Methods:  Online databases (MEDLINE, Meditext, PsycINFO, Web of Science) and reference lists
searched up to August 2005. Search terms: chlamydia, attitude, attitude to health, interview, qualitative,
women. Eligibility criteria: about chlamydia, included women, involved interviews/surveys/focus groups,
looked at women's views/opinions/attitudes, published in English. Thematic analysis identified the main and
recurrent themes emerging from the literature. We compared our thematic analysis with the Theory of
Planned Behaviour to provide a model that could assist in planning chlamydia screening programs.
Results: From 561 identified articles, 25 fulfilled inclusion criteria and were reviewed. 22: USA, UK; 3:
Holland, Sweden, Australia. Major themes identified: need for knowledge and information, choice and
support; concerns about confidentiality, cost, fear, anxiety and stigma. Women are more likely to find
chlamydia screening/testing acceptable if they think chlamydia is a serious, common condition which can
cause infertility and if they understand that chlamydia infection can be asymptomatic. Women want a range
of options for chlamydia testing including urine tests, self-administered swabs, pelvic exams and clinician-
collected swabs, home-testing and community-based testing. Tests should be free, easy and quick. Women
want support for dealing with the implications of a chlamydia diagnosis, they feel chlamydia diagnoses need
to be normalised and destigmatised and they want assistance with partner notification. Women need to
know that their confidentiality will be maintained.
Conclusion: Our review found that women from various countries and ethnic backgrounds share similar
views regarding chlamydia screening, testing and diagnosis. The acknowledged importance of women's
views in planning an effective chlamydia screening program is expanded in this review which details the
nature and complexity of such views and considers their likely impact.
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Background
Chlamydia trachomatis is a common sexually transmitted
infection that can have serious consequences [1]. The
advent of nucleic acid amplification technology has made
rapid, sensitive, non-invasive testing available. Effective
treatment is also available and is safe and simple to use
[2]. Chlamydia satisfies the WHO criteria for screening
and many countries around the world already have
screening programs in place, including Sweden [3], USA
[4,5] and UK[6]. Many others including the Netherlands
[7], Denmark [7] and Australia are still considering how
best to implement chlamydia screening. Chlamydia is a
significant health problem in Australia. Notification rates
have increased 4 fold between 1997 and 2005 from 47.4
per 100,000 to 203 per 100,000 in 2005 (40,917 notifica-
tions) [8]. Australian data show that the greatest burden of
chlamydia infection is among young women aged 16 to
24 years, with over two thirds of chlamydia notifications
among women in 2005 being in this age group [8]. Aus-
tralian prevalence surveys have also shown that chlamy-
dia prevalence is higher among young women [9].
Even in countries such as Sweden where chlamydia
screening has been established since the 1980s, uptake
varies [10]. Successful programs require education of both
health professionals and the community and ultimately
need to be informed by the views of the groups being
screened. It is universally agreed that sexually active young
women (up to at least the age of 25) are an important tar-
get group. Although there are numerous published studies
looking at various aspects of women's views on chlamydia
screening, to date there are no published reviews availa-
ble.
Understanding why people do or do not take up chlamy-
dia screening can be assisted using existing psychological
theory such as the Theory of Planned Behaviour (TPB)
originally proposed by Ajzen [11]. TPB suggests that an
individual's behaviour is due to Attitude: whether the per-
son is in favour of the behaviour; Subjective Norms:
whether the person perceives that society is in favour of
the behaviour, and to Perceived Behavioural Control: the
extent to which the person feels able to enact the behav-
iour.
Our aim was to summarise and qualitatively analyse the
published international literature examining the views,
attitudes and opinions of women screened, tested and
diagnosed with Chlamydia trachomatis. We aimed to build
an evidence base to inform the design of an appropriate
and effective chlamydia screening program in Australia
[12]. We used the TPB to synthesise our findings into a
model to assist in planning chlamydia screening pro-
grams [11].
Methods
We searched the topic of chlamydia in the databases of
MEDLINE, Meditext, PsycINFO and Web of Science up to
August 2005. Other search terms used were attitude, atti-
tude to health, interview, qualitative and women. Rele-
vant articles were also identified by hand-searching
reference lists of relevant articles and from discussion with
Australian researchers in the area. Our database search
was repeated by a Melbourne University librarian to vali-
date the list of abstracts found. Abstracts in languages
other than English were excluded. The search strategy and
inclusion criteria are described in Figure 1.
NP read all 561 English abstracts. Inclusion criteria: about
chlamydia, included women, involved interviews/sur-
veys/focus groups, looked at women's views/opinions/
attitudes and were published in English. Twenty-five arti-
cles were selected for full review. NP read and reread all
full text papers retrieved, summarised their settings, sub-
Literature Search Figure 1
Literature Search. Figure 1 shows the search terms used 
in each database (MEDLINE, Meditext, PsycINFO, Web of 
Science). A flow diagram illustrates how many articles were 
generated from each source and the inclusion criteria used 
to select the 25 articles for full review.
MEDLINE, Meditext, PsycINFO, Web of Science (August 2005)
• chlamydia
• attitude
• attitude to health
• interview
• qualitative
• women
exploded
MeSH text
words
MEDLINE:
chlamydia AND
attitude AND
attitude to health
limited to humans
AND English
= 232 articles
MEDLI NE:
chlamydia AND
interview limited to
humans AND English
= 81 articles
MEDLINE:
chlamydia AND
qualitative
limited to humans
AND English
= 35 articles
PsycINFO:
chlamydia AND
attitude
= 125 articles
PsycINFO:
chlamydia AND
interview
= 41 articles
PsycINFO:
chlamydia AND
women
= 33 articles
Meditext:
chlamydia AND
attitude
= 6 articles
Web of Science:
chlamydia AND
attitude
= 8 articles
hand searching references of
relevant articles and discussion
with other researchers
Contains interviews, surveys or focus groups
= 25 articles for reviewBMC Public Health 2006, 6:221 http://www.biomedcentral.com/1471-2458/6/221
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jects and findings, made an assessment of the quality of
the different studies and applied the initial thematic anal-
ysis. JG, RP, CF and JH were randomly allocated six papers
each to read and review to further define and validate NP's
summary of the findings, assessment of the quality of the
studies and impression of the themes emerging from the
data. JG, RP and NP discussed the thematic analysis and
reached consensus on the main and recurrent themes
which relate to women's views on chlamydia screening,
testing and diagnosis. As a group JG, RP and NP compared
our thematic analysis with the Theory of Planned Behav-
iour [11]. We were interested to discover whether the TPB
could help draw together our thematic analysis into a use-
ful model for designing a chlamydia screening program.
RP has the most expertise with psychological theory
within our group and assisted us with the application of
the TPB model.
Results
Of the 561 articles we identified, twenty-five fulfilled the
inclusion criteria. Eight of the articles reviewed report on
studies that took a predominantly qualitative approach;
fourteen on studies that were predominantly quantitative
in nature and three on studies that blended qualitative
and quantitative approaches. Table 1 sets out those stud-
ies including a qualitative component and Table 2 those
studies including a quantitative component. Ten studies
were from the USA, 12 from the UK and one each from
Netherlands, Sweden and Australia respectively. Seven
studies were community-based surveys, 18 were based in
a clinical setting. The Australian study is an unpublished
Master's thesis, the Dutch article and two of the UK arti-
cles are published letters. Thematic analysis of the sum-
marised findings from both the qualitative and
quantitative studies revealed recurrent themes relating to
factors that promote women's acceptance of chlamydia
screening and factors that make chlamydia screening less
acceptable to women.
Themes derived from qualitative and quantitative studies
What factors promote screening?
There were several common themes identified in our
review which relate to factors women think promote
acceptance of chlamydia screening and which make a
diagnosis of chlamydia easier to deal with.
Accurate knowledge about chlamydia [13-21]
These related to the type and level of information women
possess about chlamydia and chlamydia screening.
Women are more likely to accept screening for chlamydia
if they think that chlamydia is a serious condition, if they
think that chlamydia is common, if they are aware that a
woman who has chlamydia may have no symptoms, if
they think that tests are important, if they understand the
testing process, if they are aware of the long-term effects of
chlamydia infection and in particular if they are aware of
the possibility of infertility. One study strongly empha-
sised the need to focus on the positive aspects of choosing
to have chlamydia tests (such as exhibiting responsible
self-caring behaviour) rather than focusing on the "nega-
tives" of a chlamydia diagnosis. Women want better
access to information about chlamydia via health leaflets,
doctors, schools, magazines, billboards and TV ads and
some indicated that they feel that humour is an important
tool in conveying this information.
Feeling chlamydia is personally relevant [13,16,20,22-25]
There were also various personal factors that influenced
acceptance of chlamydia screening. These included a
woman being more likely accept a chlamydia test if she
had a new partner, if she had had "other" non-steady part-
ners in the last six months, if she perceived herself or her
partner to be at risk of chlamydia, if she or her partner had
symptoms, if she thought she might be pregnant, if she
had previously had a diagnosis of chlamydia, if she had a
good rapport with the person offering her the test and if
she was interested in her own health maintenance.
Choice: having multiple options for chlamydia testing 
[14,18,20,21,26-33]
Another significant theme identified was women's desire
for "choice" in how chlamydia screening is offered.
Women want to have a range of testing options including
urine tests, self-administered swabs, pelvic exams and cli-
nician-collected swabs, home-testing options, self-testing
options, outreach health professionals and mobile health
vans. Women feel it is important that they are "in control"
of chlamydia tests and results. They want to be able to
choose to participate in chlamydia screening, to be
actively offered screening and to be able to refuse screen-
ing.
Pragmatic aspects: it needs to be easy [19,20,23,27,34]
Another theme related to pragmatic aspects of chlamydia
screening. Women want access to free chlamydia tests.
They think incentives for testing would improve uptake.
Testing needs to be easy and quick (urine tests have good
acceptability). PAP tests are thought to be a good time to
offer a chlamydia test.
Feeling supported to deal with a chlamydia diagnosis [14,35,36]
Finally themes relating to support needed when dealing
with a diagnosis of chlamydia were common. Women
want support for partner notification, for dealing with a
positive chlamydia diagnosis and with the fear of its
future effect on reproductive health. Women feel chlamy-
dia needs to be normalised and destigmatised.B
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Table 1: Summary of the studies that included a qualitative component. Describes the settings, subjects and findings of the 11 studies that included a qualitative component.
Setting Subjects Study Findings
[14] USA, non-clinical and non-
medical setting
32 men (aged 15–20 years) and 23 women (aged 16–24 
years). Participants were sourced half from a job 
program and half from the juvenile justice system. All 
were out of school and were deemed "high risk" for 
STI acquisition.
Qualitative: 8 focus group 
interviews
Barriers to screening: confidentiality and privacy concerns; fear of a positive 
diagnosis and the negative consequences of chlamydia infection; ignorance of the 
significance of a chlamydia diagnosis
Facilitators of screening: the option of home testing, improved information about 
chlamydia; support for dealing with a diagnosis of chlamydia; promotion of 
chlamydia screening as "exhibiting responsible behaviour"
[35] Sweden, urban, youth clinic 5 women and 4 men aged 18–22 years. All had a 
positive chlamydia test and were patients of the 
interviewer. All the men were contacted through 
partner notification.
Qualitative: In depth 
interviews
Attitude to being diagnosed with chlamydia: shame/guilt (worse for women); 
satisfaction (more for men). Support: Women told mothers, sisters and friends; 
men told no one. Beliefs: having sex with someone "known" protects against 
catching an STI; using condoms with someone you like is an expression of distrust; 
men felt women should be "condom-promoters"
[15] UK, urban, sexual health 
clinic (London)
12 men (16–44), 12 women (16–34), heterosexual and 
a chlamydia diagnosis (82% participation)
Qualitative: Semi 
structured interviews
Attitude to chlamydia diagnosis: worry about infertility; self-blame
Knowledge: some people thought chlamydia was a relatively minor infection and 
put off seeking treatment
[23] UK, urban, 2 genitourinary 
medicine (GUM) clinics and 
1 family planning (FP) clinic 
(East Midlands)
37 women (15–53) had been screened for chlamydia, 
3=black, 34=white, socially diverse backgrounds. All 
women who agreed to participate were included.
Qualitative: Semi 
structured interviews
Reasons for STI screening: own symptoms; partner's symptoms; partner's 
behaviour; own behaviour and health maintenance Barriers to STI screening in 
General Practice: relationship with the GP; views of the quality of clinical care; 
need for confidentiality and accessibility
Facilitators to STI screening: raise concerns about STIs at the same time as Pap 
tests; help women feel "in control" of receiving their test results
[36] UK, urban, genitourinary 
medicine (GUM) clinic, 
family planning (FP) clinic 
(Glasgow)
17 women (18–29) with a current or recent diagnosis 
of chlamydia. The first 17 who agreed to participate 
were included (10 from GUM and 7 from FP response 
rate = 62%)
Qualitative: Semi 
structured interviews
Attitude to chlamydia diagnosis: stigma attached to having an STI; stigma about 
attending a sexual health service; anxiety about partner notification; fears about 
future effects on reproductive health and fertility. Facilitators: normalise and 
destigmatise chlamydia diagnosis; provide support for partner notification; provide 
support for dealing with uncertainties regarding future infertility
[26] USA; population based 
non-medical setting
120 men and women aged 18–25, 55% were female (n 
= 66) and 61% were aged 18–21, 41% were white, 22% 
black and 33% Latino.
Qualitative: Semi 
structured Computer-
Assisted Telephone 
Interviews (CATI)
Attitude to chlamydia diagnosis: shock, anger, embarrassment, disappointment 
(50% of participants); relief (14%); negative effect on personal relationships; fear; 
depression; low self-esteem; health-related concerns (only 4 participants); would 
seek treatment for chlamydia (most participants). Knowledge: 25% of participants 
believed chlamydia is very difficult to treat. Barriers to chlamydia testing: cost/time 
involved in seeking treatment; stigma. Facilitators of chlamydia testing: home urine 
testing/urine self-test kits. Advantages to home testing: privacy, increased testing, 
convenience, lower cost (no need to see a doctor). Disadvantages to home 
testing: doubts about test accuracy, doubt whether people at risk would use home 
tests and whether people with a positive result would get treated. Advantages of 
being given results over the phone: privacy, convenience, learning STD status, 
having control over the process Disadvantages of being given results over the 
phone: risk of a positive test and no professional to talk to face-to-face, fear of a 
positive test or of being overheard might put people off calling.B
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[18] Australia, urban, youth 
clinic (Melbourne)
25 homeless young people aged 16–26; 19 male and 6 
female, level of schooling varied from Year 8 to Year 
12
Qualitative: 6 focus groups 
with 4 to 6 participants.
Participants had limited knowledge about chlamydia. Suggested ways to 
disseminate information: school, free entertainment magazines, billboard 
advertising, TV ads and pamphlets distributed by community groups. Humour 
seen as a useful tool. Barriers to screening: embarrassment, cost, ignorance. 
Suggested facilitators: mobile health van, free medical care (bulk billing), improved 
advertising and awareness of chlamydia, incentives for testing, outreach health 
professionals, self-testing.
[21] UK, urban, general practice 
(8 general practices) 
(Edinburgh)
20 women who had participated in a pilot of 
opportunistic chlamydia screening including both those 
with positive (4) and negative (14) results and those 
still waiting for results (2).
Qualitative: Semi-
structured interviews
Perception of risk of chlamydia infection: most women said they were not 
worried whilst waiting for results as they did not perceive themselves as being "at 
risk". Most had not heard of chlamydia before and therefore thought it was 
uncommon. Women found it difficult to accept that chlamydia could be 
asymptomatic. Women based their assessment of the risk of chlamydia infection 
on its perceived prevalence, on their previous experience, on their own or their 
partner's sexual history and on the presence or absence of symptoms. Views 
about chlamydia screening: all women were glad to have been screened. Reasons 
included: awareness of the risk of infertility, the ease of testing and knowing it can 
be treated with antibiotics. Information: This was important both in deciding 
whether to accept a test and in dealing with results. Knowing that if they did have 
chlamydia it could be treated with antibiotics was important to several women. 
Knowing that chlamydia could be asymptomatic for some time was important for 
women in dealing with the implications of an infection. Choice: Many women felt 
that although routine screening was a good idea, choosing to participate or not 
was very important. Younger women however thought being offered screening 
directly was good as they might not have asked for it.
[34] UK, urban, population 
based probability sample 
(London)
36 sexually experienced men and women aged 18–44 
(equal numbers of men and women)
Qualitative: In depth face-
to-face interviews
Factors influencing an individual's decision to participate in chlamydia screening by 
urine included: trust and rapport with the interviewer who was inviting them to 
have the test, understanding the aims of the test and what would happen to the 
urine sample, a sense of obligation, not feeling embarrassed, the perceived 
importance of the test and the opportunity to receive free testing.
[38] UK, urban, family planning 
clinic (Nottingham-shire)
4 women aged <25 who had had a positive chlamydia 
result 6 months previously.
Qualitative: In depth face-
to-face interviews
Feelings about a diagnosis of chlamydia included: shock, worry, unhappiness, 
embarrassment and surprise. Attitude to partner notification: 3 felt embarrassed 
about the need to trace contacts but all 4 women attempted to do so. Concern 
for the future: all were very concerned about the long term effects of chlamydia if 
left untreated.
[20] UK, urban, general 
practice, family planning 
(FP), genitourinary 
medicine (GUM) clinics, 
adolescent sexual health 
clinics, termination of 
pregnancy clinics and 
women's services in 
hospitals (antenatal, 
colposcopy, gynaecology 
and infertility clinics).
25 sexually active women aged 16–24 attending a 
range of healthcare settings, who had been screened 
for chlamydia, completed a questionnaire on the 
acceptability of screening and volunteered to 
participate in an in depth interview on their views on 
chlamydia screening. (80 people gave their contact 
details but only 25 were available for interview)
Qualitative: In-depth 
interviews
Women were pleased to be offered screening. A minority were concerned that 
the offer of screening meant they had been singled out as being "at risk" of an STI. 
Participants attending GUM or FP clinics were most comfortable with being 
screened. Motivations for accepting screening included: awareness that chlamydia 
infection can be asymptomatic, (many reported that they would not have sought 
out screening if it had not been opportunistically offered to them), also exposure 
to "formal" information (health professionals, leaflets, publicity campaigns) and 
"informal" information (family and friends). Women felt able to refuse screening. 
The most important factors influencing the decision to accept screening were 
having the perception of being at risk of infection, awareness of the possible long-
term effect on fertility and thinking that chlamydia was easily treated. All the 
women interviewed found giving a urine sample acceptable. The majority said they 
would have declined screening if it involved a clinician-collected swab.
Table 1: Summary of the studies that included a qualitative component. Describes the settings, subjects and findings of the 11 studies that included a qualitative component. (Continued)B
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Table 2: Summary of the issues addressed in the studies that included a quantitative component. Summarises the research questions addressed in the studies that included a quantitative 
component, the number of studies asking each question, the location of the studies and number of women represented in combined studies from each location, as well as the median and 
range of responses to each research question.
Research question Number of studies 
asking question
Location of studies and 
number of women in 
combined studies from 
each location
Median and range of responses (median calculated by 
placing the response percentages in value order and finding 
the middle value)
Ref
Number of women accepting urine screening for 
chlamydia
4 UK (n = 27470) 71–83% (median 76%) of women accepted screening for chlamydia 
by urine
[20, 25, 28, 34]
Readiness to seek chlamydia screening on partner change 3 USA (n = 736) 28–57% (median 47%) of women reported they currently seek 
chlamydia screening with partner change; 28–50% reported they are 
ready to screen on partner change; 11–15% are thinking about being 
ready to seek screening on partner change and 4–7% are not ready 
to seek screening on partner change
[13, 16, 22]
Knowledge of chlamydia 3 UK (n = 737) 60–93% of women had heard of chlamydia, 26–86% knew chlamydia 
could be asymptomatic and 68–82% were not aware of the 
consequences of untreated infection.
[17, 19, 38]
Acceptability of chlamydia screening in different 
healthcare settings: general practice, family planning 
clinics, termination of pregnancy clinics, colposcopy 
clinics, antenatal clinics, youth clinics, infertility clinics, 
genitourinary medicine clinics, gynaecology clinics
2 UK (n = 22126) Acceptability of chlamydia screening in these healthcare settings 
ranged from 38–100% (median 82%)
[19, 20]
Acceptability of self administered swab (SAS) vs. first void 
urine (FVU) vs. pelvic exam and clinician-collected swab 
for chlamydia screening
3 USA (n = 2093) All 3 studies showed FVU was the preferred method of chlamydia 
screening over SAS and pelvic examination but FVU and SAS were 
similar in ease and acceptability.
[27, 29, 30]
Participation in home screening for chlamydia and 
preferred test (urine or vaginal swab)
3 UK (n = 208), USA (n = 98), 
Holland (n = 189)
Participation rate in home testing ranged from 31–52% (median 
39%). Urine testing was more often accepted than vaginal swab 
testing: 47–63% relative to 32–37%.
[31–33]
Rates of partner notification following a diagnosis of 
chlamydia
2 UK (n = 73), USA (n = 55) Both studies report a 75% rate of partner notification [24, 25]BMC Public Health 2006, 6:221 http://www.biomedcentral.com/1471-2458/6/221
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What gets in the way of chlamydia screening?
Numerous themes related to factors which make chlamy-
dia screening less acceptable to women
Ignorance and inaccurate information about chlamydia 
[14,18,21,26,35]
Many of these themes also relate to type, level and accu-
racy of information women possess about chlamydia.
Women are less likely to accept chlamydia screening if
they have not heard of chlamydia, think chlamydia is a
"minor" infection or think chlamydia is uncommon, if
they believe chlamydia is very hard to cure, if they think
the tests are not accurate and if they think "you would
know if you had it" i.e. that there would be symptoms. A
woman is also less likely to think that her sex partner (and
hence herself) is at risk of chlamydia if her partner is
"known" (the definition of "known" varies considerably –
may sometimes only be "known" for a few hours).
Denial [14,21]
Denial was also identified as a significant theme, includ-
ing a woman not wanting to acknowledge sexual activity,
thinking herself at low risk of having chlamydia, and
thinking her partner is at low risk of having chlamydia.
Moral connotations and stigma [18,26,35,37,38]
In many studies women reported feeling put off chlamy-
dia screening by the moral connotations of a chlamydia
diagnosis. They reported feeling shame, guilt, self-blame,
embarrassment, anger, low self-esteem, shock, worry,
unhappiness and surprise on being diagnosed with
chlamydia. A diagnosis of chlamydia is seen as having a
strong stigma attached to it. Some women believe that to
use condoms shows distrust of your partner.
Fear and anxiety [14,26,36]
Themes of fear and anxiety were common. Women
reported feeling fearful about infertility and future repro-
ductive health, anxious about partner notification and
worried about the negative effect of a chlamydia diagnosis
on their personal relationships.
Confidentiality and privacy concerns [13,14,22,23]
Many women had confidentiality and privacy concerns.
These included concerns about the confidentiality of
attending a clinic and of results, wanting to keep STI
screening private, not wanting anyone to know and think-
ing General Practice is not confidential or private enough
for chlamydia testing.
Pragmatic aspects – women are put off if screening is difficult or 
uncomfortable [13,18,23,32]
Pragmatic aspects were again important. Women found
the time and cost involved in a having a chlamydia test
put them off being tested. Having to physically go to a
clinic as well as discomfort with sample collection (espe-
cially pelvic examinations and physician-collected swabs)
were also barriers to accepting chlamydia screening.
Synthesising the findings using the Theory of Planned 
Behaviour
The Theory of Planned Behaviour (TPB) [11] helps to
understand the factors that affect the human decision-
making process. The themes derived from our review
appear to accord well with the concepts of Attitude, Sub-
jective Norms and Perceived Behavioural Control inher-
ent in the TPB. Figure 2 illustrates how the TPB can be
used to group findings from the thematic analysis in a way
that could usefully inform the development of a public
health campaign or chlamydia screening program. Some
of the data in our themes did not fit into the TPB model,
notably women's desire for better access to information
on chlamydia, the suggestion regarding the use of humour
to promote chlamydia awareness, and finally women's
desire to be offered screening but to feel able to refuse. The
area of Subjective Norms was less supported by our review
than either Attitude or Perceived Behavioural Control but
still has adequate data. Overall the TPB appears to be a
useful way of conceptualising the findings of this litera-
ture review and may assist in chlamydia screening pro-
gram planning and implementation.
Discussion
The studies reviewed report on the views of a total of 26
256 women from five countries (98% from the UK and
USA) on chlamydia screening, testing and diagnosis.
Major themes identified relate to the need for knowledge
and information, choice and support and to concerns
about confidentiality, cost and stigma. Fear and anxiety
were commonly expressed.
Major findings
While it is clear that accurate knowledge about chlamydia
is fundamental to women's increased acceptance of
screening, the literature suggests that numerous factors
impinge on women's incorporation and potential appli-
cation of such knowledge. Some of these factors are more
amenable than others to public health measures. Denial,
for instance, refers to a self-protective, defensive mode of
thinking which is adopted in the face of rational evidence
[39]. Personal moral views may also be maintained
impervious to any presentation of relevant facts. Never-
theless the challenge remains to devise creative
approaches to the way knowledge is presented which not
only inform but simultaneously normalise and destigma-
tise the subject-matter, allowing it to become personally
relevant to those whose tendency may have been to shrug
it off. The literature surveyed contained at least one rele-
vant pointer when respondents singled out for mention
the importance of humour. The belief that to wear a con-BMC Public Health 2006, 6:221 http://www.biomedcentral.com/1471-2458/6/221
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dom shows distrust of your partner is obviously one
which bypasses the rational and maintains a hold which
is not easily loosened. Such challenges suggest the impor-
tance of taking a broad, multi-disciplinary approach to
devising public health programs. Somewhat less difficult
to address, although still personal in nature, are the fac-
tors grouped under the subheading of fear and anxiety,
particularly if opportunities are built into programs for
discussion of fears and for sensitive, tangible support
regarding partner notification. Regarding women's
reported concerns about privacy and confidentiality, we
need to consider whether present safe-guards are, in prac-
Application of the Theory of Planned Behaviour Figure 2
Application of the Theory of Planned Behaviour. Figure 2 uses Ajzen's Theory of Planned Behaviour to generate a con-
ceptual model to aid in understanding how the various themes identified influence women's acceptance or rejection of chlamy-
dia screening
Attitude: encourage attitudes that will influence
women to be more in favour of chlamydia testing
Favourable attitudes: thinking chlamydia is common,
can happen to people like them, can be asymptomatic,
is serious and has long-term effects and can cause
infertility; knowing chlamydia can be treated; thinking
testing for chlamydia is important; feeling chlamydia
testing is personally relevant (especially if they  have
symptoms, a previous diagnosis of chlamydia, a new
partner, casual partners, or think themselves or their
partner likely to be at risk of chlamydia)
Subjective Norms: encourage
women to see chlamydia screening
as socially approved behaviour
 Guiding Principles: promote chlamydia
testing as “responsible behaviour”,
normalise and destigmatise chlamydia
testing and diagnosis, provide
respected/trusted testers
Perceived Behavioural Control: encourage women
to feel able to have chlamydia tests
Guiding Principles: provide women with a sense of
control over testing and their results, access to non-
invasive tests, a range of testing options (urine, self-
collected swab, clinician collected swab), home-
testing, offer chlamydia tests with PAP tests, provide
outreach and mobile services; provide support for
partner notification; provide free testing; ensure privacy
and confidentiality; help women feel they understand
the testing process
Increased Intention
to seek chlamydia
screening:
Behaviour:
increased chlamydia
screeningBMC Public Health 2006, 6:221 http://www.biomedcentral.com/1471-2458/6/221
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tice, adequate and be ready to identify and implement any
necessary improvements. We need to be sensitive to fears
in this area and develop systems and visible modes of
operation which go some way to allaying such fears of the
public. Feedback on the pragmatic aspects of testing con-
tains important detail giving us positive direction about
what women find important. In the light of Ajzen's TPB it
is important to ensure that programs have elements aimed
at addressing Attitude, Subjective Norms and Perceived
Behavioural Control. Attitude: encourage attitudes that
will influence women to be more in favour of chlamydia
testing. Subjective Norms: encourage women to see
chlamydia screening as socially approved behaviour. Per-
ceived Behavioural Control: encourage women to feel able
to have chlamydia tests.
Limitations
Our review is limited in that we only included studies
written in English and also by the fact that 98% of the
studies selected deal with the views of women from the
USA and UK. The quality of the studies reviewed also var-
ied considerably. Some of the qualitative studies had very
small number of participants and participant selection
was often non-random [18,35]. For example one study
which used a qualitative approach reports on a small
cross-sectional study interviewing only four women with
positive chlamydia tests [38]. The scope of the research
questions addressed by some of the quantitative studies
was sometimes limited to "is urine testing acceptable to
women?"[28,34] or even just "do women return a urine
chlamydia test kit?"[33]. However despite this variability
all studies had similar findings. It is striking that the find-
ings support each other strongly, irrespective of whether
the studies were conducted using predominantly qualita-
tive or quantitative approaches.
In our thematic analysis we relied initially on the work of
NP, with the rest of the team discussing her suggested
themes subsequently. This may have biased our thematic
analysis although it is hoped that our team discussion
helped to validate the theme definitions. A further limita-
tion of our study relates to the timing of our use of the
TPB. We applied the TPB sequentially following our the-
matic analysis. This may limit the applicability of the TPB
model we have derived, as some important information
may have been missed. Nevertheless it proved a useful
tool to us as we processed our findings. The research team
vigorously discussed the suggested themes and a sub-
group worked on applying the TPB. We reached consensus
on our themes and our application of the TPB model.
Recommendations
From our review we can draw some lessons for designing
an effective chlamydia screening program aimed at
women. It is important to raise awareness about chlamy-
dia in the community to be screened, to increase the
access of young women in particular to accurate informa-
tion about chlamydia and to explore creative ways to nor-
malise and destigmatise chlamydia. Chlamydia testing
needs to be free, easy to access, private, as non-invasive as
possible and should be available in a variety of settings.
Beyond facilitating the actual diagnosis, support emerges
as equally crucial, to help women cope with a diagnosis of
chlamydia and to assist them with partner notification.
Although these generalised findings emerged from studies
involving multi-ethnic groups from more than one coun-
try, it may be important in the Australian context for spe-
cific studies to explore the views of various groups of
young Australian women, including those of Aboriginal
women in urban, rural and remote areas.
Conclusion
Our review looks at the views on chlamydia testing,
screening and diagnosis of more than 26 000 women
from 5 countries (predominantly the UK and USA).
Women from various countries and ethnic backgrounds
shared similar views. These are significant considerations
when planning future chlamydia screening programs and
public health initiatives. Our review suggests women will
be more in favour of chlamydia testing and screening if
they think chlamydia is common, can happen to people
like them, can be asymptomatic, is serious and has long-
term effects, can cause infertility, if they know chlamydia
can be treated and if they think testing for chlamydia is
important. It may be helpful to promote chlamydia test-
ing as "responsible behaviour," to normalise and destig-
matise chlamydia testing and diagnosis and to offer
testing by respected/trusted testers. Women may be more
likely to accept chlamydia screening if they have access to
non-invasive tests, to a range of testing options (urine,
self-collected swab, clinician-collected swab); home-test-
ing, outreach and mobile services, if chlamydia testing is
free, if they are provided with support for partner notifica-
tion and if they feel confident that their privacy and con-
fidentiality will be maintained. While these criteria hold
true across national and ethnic differences in the popula-
tions which were the subject of the literature reviewed to
date, the possibility arises that other groups may have a
unique point of view. In terms of developing a chlamydia
screening program for Australia this highlights the need
for specific further research on Australian women's views
about chlamydia screening. testing and diagnosis, before
any one chlamydia screening program is implemented.
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